Brands Browse Interactions Pill ID Categories

Loading…

Drugvu is an independent compilation of publicly-disclosed pharmaceutical regulatory information. It is not affiliated with the FDA, EMA, MHRA, Health Canada, TGA, TİTCK, PMDA, or any pharmaceutical manufacturer or regulatory agency.

This is not medical advice. Always consult a qualified healthcare professional for medical decisions.

About Editorial process Editorial team Data sources Methodology Corrections Contribute Privacy Terms DMCA Contact

Mirabegron and Lorlatinib: Minor Interaction - Drugvu

🏠›Mirabegron›Interaction with Lorlatinib

Mirabegron + Lorlatinib

Drug interaction

Minor interaction

A minor drug-drug interaction between Mirabegron and Lorlatinib is recorded in public interaction data. Severity reflects the source classification; it does not describe your individual risk. Do not start, stop, or change either medicine based on this page.

What “minor” means

A minor interaction is usually of limited importance for most people, though it is still worth being aware of.

What to do

Usually no change is needed - but ask your pharmacist if you notice anything unusual.

Side effects reported for both

Mirabegron and Lorlatinib are each reported to cause the effects below. Taking them together can make these more likely or more pronounced - one of the ways a drug interaction matters.

AstheniaPeripheral Swelling

Compiled from public adverse-event reports; an overlap, not a confirmed causal mechanism.

The two medicines

Active ingredient

Mirabegron

Drugs For Urinary Frequency and Incontinence

Uses, side effects, dosage →· 200 recorded interactions

Active ingredient

Lorlatinib

Anaplastic Lymphoma Kinase (Alk) Inhibitors

Uses, side effects, dosage →· 439 recorded interactions

Source

DDInter 2.0 (CC-BY 4.0, https://ddinter.scbdd.com)

This is not medical advice. Drugvu is an independent aggregator of public records.